Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil

Aggressive Squamous-Cell Carcinoma of the SkinAggressive, rapidly progressive cutaneous squamous-cell carcinoma emerged in a patient taking ruxolitinib and a patient taking belumosudil for chronic graft-versus-host disease.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2023-07, Vol.389 (2), p.188-190
Hauptverfasser:	Lee, Gun Ho, Guzman, Anthony K., Divito, Sherrie J., Soiffer, Robert J., Silk, Ann W., Schmults, Chrysalyne D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetamides Antineoplastic Agents - therapeutic use Biopsy Bone Marrow Transplantation Carcinoma, Squamous Cell - drug therapy Dermatology Drug dosages FDA approval Graft versus host disease Graft-versus-host reaction Hematology Humans Leukemia Oncology Patients Protein Kinase Inhibitors - therapeutic use Pyrazoles - adverse effects Sinuses Skin Cancer Skin Neoplasms - drug therapy Squamous cell carcinoma Surgery Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aggressive Squamous-Cell Carcinoma of the SkinAggressive, rapidly progressive cutaneous squamous-cell carcinoma emerged in a patient taking ruxolitinib and a patient taking belumosudil for chronic graft-versus-host disease.
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJMc2304157